Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RGGI News: ResGreen Announces Partnership with Wearable Tech Pioneer ProGlove
SHELBY TOWNSHIP, Mich., June 27, 2023 (GLOBE NEWSWIRE) -- ResGreen Group International, Inc. (RGGI), a next-gen mobile robot and software solutions company, announced today it is partnering with wearable tech pioneer ProGlove to increase collaboration between workers and automated equipment. ProGlove provides durable, wearable barcode scanners that can be easily integrated with ResGreen’s BotWay software and LilBuddy Autonomous Mobile Robots (AMRs).
“We are thrilled to partner with a progressive company like ProGlove that is committed to achieving Industry 4.0 through the Internet of Things (IoT), connectivity and advanced technology,” said Parsh Patel. “We design all of our products to interface with a wide variety of devices and systems like ProGlove’s scanners and software.”
"This partnership is yet another major step to drive human-centered productivity across the shop floors and assembly lines of the world,” said Adrian Armenta, Strategic Alliance Partner Manager at ProGlove. “ResGreen’s cutting-edge technology is like a natural match for our wearable tech solutions. Our joint offering will not only promote worker well-being and human-machine collaboration, it will also set up a fast path to enhance efficiency and productivity for the organizations that are deploying it.”
ProGlove provides a wide variety of fast, light and multi-range barcode scanners that optimize hands-free scanning operations. These scanners can be integrated with LilBuddy AMR to increase productivity in supply chains operations, assembly lines and logistics centers. After a worker scans a product or load, it can be moved to its next destination by LilBuddy to minimize walking and reduce monotonous tasks for workers.
ResGreen’s LilBuddy AMR is just 17” x 17” and uses natural feature SLAM guidance to move loads up to 220 pounds (100 kg.) without tape, reflectors, or tags. LilBuddy’s modular design enables it to tunnel under customized load handling frames and hitch to them through an automatic pop-up pin.
About ResGreen Group International, Inc. (RGGI)
ResGreen is a premier provider of automated material handling solutions, including interoperable software, Autonomous Mobile Robots (AMRs), Automatic Guided Vehicles (AGVs) and industrial automation devices. Connectivity and collaboration are the cornerstones of ResGreen’s products, as well as Industry 4.0 and 5.0. ResGreen’s team of experienced engineers use the Internet of Things (IoT), MQTT protocol and Robot Operating System (ROS) to design technologies that interface with a wide variety of automated equipment, electronic components and software systems. For more information, visit http://www.resgreengroup.com.
About ProGlove
Founded in 2014, ProGlove provides smart wearable scanner solutions that fuel a continual stream of worker-driven productivity gains. More than 2,000 global industrial customers trust in ProGlove’s innovations. Organizations deploy them to optimize worker experience, maximize uptime, and get more done with existing teams. The company’s hard- and software solutions augment the boots on the ground and promote human-machine collaboration. This brings speed, accuracy, guidance, and ergonomics to the shopfloor workers. Thus, ProGlove’s wearable tech solutions provide organizations with unique shopfloor and device data points. This powerful combination of soft- and hardware enables significant process optimizations, error reductions, and worker well-being enhancements. Pioneers and innovators of all sizes in automotive, manufacturing, retail, and logistics rely on ProGlove. Users report productivity gains of up to 20 per cent and up to 33 per cent fewer errors. With each scan, they can leverage time savings of up to 6 seconds per scan. ProGlove’s customers include organizations such as BMW, DHL, Gap Inc. and Lufthansa Technik Logistik Services. The wearable tech pioneer employs more than 350 people from over 30 countries with offices in Chicago (US), Coventry (UK), Munich (Germany), and Belgrade (Serbia). More information is available at http://www.proglove.com.
Contact:
Sarah Carlson
scarlson@resgreengroup.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d51cc1be-564a-418e-b541-ceaed5497373
https://www.globenewswire.com/newsroom/ti?nf=ODg2NTM4NiM1NjY3MjA1IzIyNTM0NTI=
https://ml.globenewswire.com/media/MDQ2NDlhMDktYzU1OC00ZmJkLTkzOWQtNjYxYzFlYmZkYmExLTEyNjUwMDU=/tiny/ResGreen-Group-International-I.png
ResGreen and ProGlove Partnership
A worker uses ProGlove’s barcode scanner and ResGreen’s LilBuddy AMR to improve productivity and efficiency.
Source: ResGreen Group International Inc
$LPTV Unlocking the Power of Digital Out-of-Home Advertising: A Promising Growth Opportunity in the Changing Landscape of Advertising https://www.tgd8hjs.com/3J67C1/4QX811T/
$KOAN 8k UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 20, 2023
Resonate Blends, Inc.
(Exact name of registrant as specified in its charter)
Nevada 000-21202 58-1588291
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
26565 Agoura Road, Suite 200
Calabasas, CA
91302
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: 571-888-0009
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
? Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Section 1 – Registrant’s Business and Operations
Item 1.01. Entry Into a Material Definitive Agreement.
Merger Agreement
On June 20, 2023, Resonate Blends, Inc. (“Parent”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Pegasus Specialty Vehicles, LLC, an Ohio limited liability company (the “Company”), and Pegasus Specialty Holdings LLC, an Ohio limited liability company and wholly-owned subsidiary of Parent (“Merger Sub”).
The Merger Agreement provides that at the closing (the “Closing”), subject to the terms and conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly-owned subsidiary of Parent. At Closing of the Merger, the issued and outstanding common shares of the Company (“Company Common Shares”) will automatically be converted into the right to receive an aggregate of 623,500 shares of Series AA Preferred Stock of Parent (the “Merger Consideration”).
Each of the Company, Parent, and Merger Sub has made various representations and warranties and agreed to certain covenants in the Merger Agreement, including a covenant by Parent that it would raise $3,000,000 less costs in new financing at Closing, with $500,000 of such amount less costs loaned pre-Closing to the Company under a secured promissory note. The Company has a covenant that it would grant a security interest to Parent in all of its assets on the $500,000 loan in favor of Parent, subordinate to other security interests as to the same collateral.
Consummation of the Merger is subject to the satisfaction or, if permitted by applicable law, waiver, by Parent, the Company, or both of various conditions. For the Company, these conditions include, without limitation, (i) an agreeable plan to spin out the existing Parent cannabis assets and operations, (ii) an agreeable plan to transfer the outstanding shares of Series C Preferred Stock of Parent to Brian Barrington simultaneously to the date of the aforementioned spin-out; (iii) an agreeable plan to retire the Series E Designation; (iv) financing by Parent of $3,000,000 less costs; (v) the filing of the Certificate of Designation for the Series AA Preferred Stock with the Secretary of State of Nevada; and (vi) certain other customary conditions. For the Parent, these conditions include, without limitation, (i) a secured promissory note issued by the Company to Parent in the amount of $500,000 with the collateral being a UCC lien subordinate to other lenders; (ii) the payback by Parent of certain advances contributed by corporate officers and others in the Parent in an amount not to exceed $140,000; (iii) resolutions of the equity holders of Company approving this Agreement and the transactions contemplated; and (iv) certain other customary conditions.
The Merger Agreement contains certain termination rights including the right of the parties to mutually agree upon termination, and by each of the Company and the Parent unilaterally if the other party has committed a violation of the covenants, representations and warranties in the Merger Agreement.
The Merger Agreement, the Merger, and the transactions contemplated thereby were unanimously approved by the board of directors of the Parent, and unanimously approved by the board of directors of the Company.
The Closing of the Merger is expected to occur as soon as practicable after the satisfaction or waiver of all the conditions to Closing in the Merger Agreement, which is currently expected to be in the 3rd quarter of calendar year 2023.
The Merger Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating risk and governing the contractual rights and relationships among the parties to the Merger Agreement. In addition, such representations, warranties, and covenants may have been qualified by certain disclosures not reflected in the text of the Merger Agreement and may apply standards of materiality and other qualifications and limitations in a way that is different from what may be viewed as material by the Parent’s shareholders. None of the Parent’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, Parent, Merger Sub, or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Parent’s public disclosures. The Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding Parent that is or will be contained in, or incorporated by reference into, the Forms 10-K, Forms 10-Q, Forms 8-K, and other documents that Parent files or has filed with the SEC.
The foregoing descriptions of the Merger Agreement and the Merger are summaries, do not purport to be complete, and are qualified in their entirety by reference to the full text of the Merger Agreement, and the exhibits attached thereto, a copy of which is attached as Exhibit 2.1 to this Current Report on Form 8-K and incorporated by reference herein.
Bridge Financing
On June 20, 2023, Parent signed a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”), pursuant to which Parent issued and sold to the Investor a 15% OID Senior Promissory Note (non-convertible), dated June 20, 2023, in the principal amount of $575,000 (the “Parent Note”). The Parent Note is secured by all of the Company’s assets under a separate security agreement between the Investor and the Company.
Parent received $500,000 from the Parent Note after applying the original issue discount to the Parent Note, $30,000 of which was used to pay a commission to a broker as placement agent and $30,000 was paid to the lender for its legal fees, and the balance was tendered to the Company for working capital under a Loan and Security Agreement (described below) (the “Company Loan”).
The maturity date for repayment of the Parent Note is September 20, 2023 and the Parent Note bears interest at 15% per annum starting 60 days after issuance and interest payable in cash monthly thereafter. Parent may prepay the Parent Note at any time, but if Parent repays the Parent Note after 60 days, it is required to pay a premium of 104% of the principal amount.
As additional consideration, Parent agreed to issue to the Investor 1,318,000 shares of its common stock as commitment shares. Parent is required to issue additional commitment shares in the event the Parent Note is not prepaid at 60 days. Pursuant to a Registration Rights Agreement (the “Registration Agreement”), Parent has agreed to register the Investor shares with the SEC no later than 90 days from the issuance of the Parent Note.
In the Purchase Agreement, Parent agreed to certain restrictive covenants, including a restriction on borrowing and a most favored nation clause in favor of Investor for any future offerings not specifically exempted.
On June 20, 2023, Parent and the Company entered into a Loan and Security Agreement in the principal amount of $575,000 secured by all of the Company’s assets but subordinate to the security interest of Investor and another lender of the Company.
The foregoing description of the Purchase Agreement, the Registration Agreement, the Parent Note, the Company Loan, and the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Purchase Agreement, the Registration Agreement, the Parent Note, and the Company Loan, which are included in this Current Report as Exhibits 10.1, 10.2, 4.1 and 10.3, respectively, and are incorporated herein by reference.
Section 2 – Financial Information
Item 2.03 – Creation of a Direct Financial Obligation
The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.
$$$$$$-LOW-FLOAT-ALERT-$$$$$$-https://newsytrends.com/2023/03/22/western-sierra-resource-corp-otcmkts-wsrc-in-focus-as-the-twitchell-dam-mitigation-project-by-mitigation-solutions-llc-msl-moves-forward/
-BREAKOUT-$$$$-JUICY LOW FLOATER WITH 1.5-BILLION CONTRACT-CALIFORNIA-
GOV-https://www.nasdaq.com/press-release/western-sierra-announces-final-contract-for-%241.5-billion-federally-funded-project
JUICY SS-https://www.otcmarkets.com/stock/WSRC/security
$SOBR premarket news! ComplianceOne Intends to Evolve its 1,100 Customers to Proactive Alcohol Testing with SOBRsafe Technology https://finance.yahoo.com/news/complianceone-intends-evolve-1-100-120000797.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$GRCU the company will release a national PR post close of all MOU’s and we will also PR the Share structure reductions confirmation once TA posts those to @OTCMarkets #OTCMarkets #OTCQB
$GRCU the company will release a national PR post close of all MOU’s and we will also PR the Share structure reductions confirmation once TA posts those to @OTCMarkets #OTCMarkets #OTCQB
— Global Roundtable Corporation (otcbb: GRCU) (@GRCU_OTC) June 21, 2023
$SMME NEWS! SmartMetric Claims Its Internally Powered Biometric Card Is the Most Advanced Biometric Card for the Credit Card Industry
https://finance.yahoo.com/news/smartmetric-claims-internally-powered-biometric-175200844.html
$MGRX sells high-quality, convenient, and affordable prescription ED medication - 100% online. With Mango, you're not just getting a prescription - you're joining a movement that's shaking up the men's health scene, one groundbreaking treatment at a time. https://www.mangorx.com
$CURR Avenir Wellness Solutions, Inc.'s (OTCQB: CURR) interview with Nancy Duitch, CEO. https://finance.yahoo.com/news/street-announces-tv-corporate-appearances-133000204.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via Yahoo Finance #wellness #interview #avenir #ceo
$GRCU HOD .0016 is NEW 52Week HIGH
https://www.barchart.com/stocks/quotes/GRCU/cheat-sheet
$EPAZ Dip is an alluring prospect for investors seeking to capitalize on market fluctuations and potential rebounds as Epazz continues to assert its presence as a provider of innovative solutions in critical industries.
$EPAZ Epazz continues to assert its position as a proactive player in the development of specialized batteries for high-powered devices and aircraft.
http://www.epazz.com
News out $KOAN merger valuation $60 million now $3.3 million
$AITX Want to Buy the Robot Dog From ‘Stars on Mars’? We Tracked It Down
https://www.distractify.com/p/robot-dog-stars-on-mars-where-to-buy
$MGRX is pleased to announce that it has been engaged as a new sponsor for Barstool Sports’ “Only Stans” podcast: https://barstoolsports.com/shows/39956939/only-stans
$ILUS "While companies like Tesla, Inc (NASDAQ: $TSLA) and Exxon Mobile Corporation (NYSE: $XOM) Exxon Mobil Corp. continue to innovate, the returns on investment are lower and longer term that a company like ILUS International Inc's (OTC: $ILUS) that anticipates a continued growth similar to Q1, throughout the rest of 2023 and beyond."
Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Downstream and Chemical. The Upstream segment produces crude oil and natural gas. The Downstream segment manufactures and trades petroleum products. The Chemical segment offers petrochemicals. The company was founded by John D. Rockefeller in 1882 and is headquartered in Irving, TX.
https://www.marketwatch.com/press-release/ilus-international-inc-otc-ilus-breaks-the-mold-of-slow-growth-companies-with-massive-557-revenue-increase-and-44-net-profit-increase-preparing-2-subsidiary-national-exchange-uplistings-for-2023-followed-by-their-own-uplist-2023-06-12
$EPAZ BigTime Penny Stocks: Exploring OTC Plays with Potential (NNAX, CLNV, EPAZ, YCRM)
06/21/2023 Epazz Inc. has recently announced the successful acquisition of an official utility patent for its revolutionary AI predictive Drone Smart Charging Pad
https://www.marketscreener.com/quote/stock/NEW-MOMENTUM-CORPORATION-120797984/news/BigTime-Penny-Stocks-Exploring-OTC-Plays-with-Potential-NNAX-CLNV-EPAZ-YCRM-44156197/
$GRCU remember post Acquisitions the company will be filing the form 10 and audits. We have a plan to not only bring value but transparency #OTCMarkets #OTC #microcap #OTCQB
$GRCU remember post Acquisitions the company will be filing the form 10 and audits. We have a plan to not only bring value but transparency #OTCMarkets #OTC #microcap #OTCQB
— Global Roundtable Corporation (otcbb: GRCU) (@GRCU_OTC) June 20, 2023
$MGRX loading up this week! Mangoceuticals Inc (NASDAQ:MGRX) Signs Sponsorship Agreement with GaS Digital Network to Promote Mango Across Multiple Hardcore Comedy Podcasts https://www.digitaljournal.com/pr/news/getnews/mangoceuticals-inc-nasdaq-mgrx-signs-sponsorship-agreement-with-gas-digital-network-to-promote-mango-across-multiple-hardcore-comedy-podcasts
$SOBR News: New Customer Gains SOBRsafe Momentum in $75 MM Justice Market, Establishes Alcohol Testing Template for Rural America https://finance.yahoo.com/news/customer-gains-sobrsafe-momentum-75-131500268.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PIII and $MMMW great interesting developments
$KRTL In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$PIII Names William Bettermann as Chief Operating Officer https://finance.yahoo.com/news/p3-health-partners-names-william-113000449.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL News: Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
https://www.krtlholding.com/about
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL tech news $MMMW product news today
$KRTL channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
$KRTL on alert! Big news out here: KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$IDVV and $MMMW with recent technology news. Please check it out.
$KRTL industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL News Alert: Lakewood, CO, May 30, 2023 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC:KRTL), an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
https://www.nasdaq.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL "Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL an innovator and pioneer in developing industry-leading cross-over tradecraft and proprietary technology in the hemp, cannabis, psilocybin, and alternative wellness sectors, announces that its wholly owned subsidiary, KRTL Biotech (“KRTL”), has entered into a channel partner agreement and white label contract with Medflow Inc. (“Medflow”), creator of a cutting-edge computer-vision based telemedicine platform. This exclusive contract allows KRTL to use and apply Medflow's innovative telemedicine technology in the alternative wellness market.
Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
$KRTL News Alert: The Company Has Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL ~ KRTL International Corp., a wholly owned subsidiary of KRTL Holding Group Inc. (OTC: KRTL), is an organization focused on green technology.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$IDVV Enters LOI to Acquire Artificial Intelligence AI Sector Technology Company https://finance.yahoo.com/news/idvv-enters-loi-acquire-artificial-134000923.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$KRTL Recent news can be found here https://www.krtlholding.com/news
$KRTL and $MMMW recent innovation news.
$KRTL "Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. Each company has its focus on specific industries including bio and Agri-Technology, to International Trade and Distribution of these technologies and services. This strategy allows KRTL Holding Group to capitalize on investment opportunities, and partnerships, creating value for its shareholders. Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
About Medflow Inc.
Medflow is a telemedicine company that offers a suite of secure and innovative telemedicine tools. Its offerings include facial recognition biometrics, zero-trust architecture, end-to-end encryption, and a variety of computer vision-based features. These tools allow healthcare providers to offer efficient and secure patient care. For more information about Medflow, visit www.medflow.com.
About Seven Cipher Group LLC
Seven Cipher Group LLC is a boutique cybersecurity firm that offers comprehensive security solutions designed for Web2 and Web3 environments. The company combines industry-leading technology and methodology to offer real-time, comprehensive analysis across your cloud and endpoint security landscape. Seven Cipher Group LLC is committed to proactively identifying and mitigating threats before they occur. For more information about Seven Cipher Group LLC, visit www.sevencipher.com.
Followers
|
287
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
54869
|
Created
|
02/20/15
|
Type
|
Free
|
Moderator mick | |||
Assistants Nilbud ospreyeye jedijazz imgoingfishing1 PhotoChick $Pistol Pete$ |
WELCOME FRIENDS TO "MICK AND FRIENDS STOCK PICKS" BOARD !!!
PLEASE POST :
1. YOUR STOCK PICK
2. WHY YOU ARE RECOMMENDING THE STOCK
3. A BIT OF INFO ON STOCK WOULD BE HELPFUL
FORUM FOR ALL STOCKS:
- NYSE
- NASDAQ
- AMEX
- OTCBB
- PINK SHEETS
- GRAY SHEETS
- FOREIGN EXCHANGES
FORUM NOT FOR ANY SPECIFIC STOCK
PLEASE, YOUR POST MUST NOT CONTAIN ANYTHING ABOUT "BASHING" ON ANY I-HUB STOCK BOARD.
THANK YOU AND ENJOY "MICK AND FRIENDS STOCK PICKS" BOARD.
Mick
PhotoChick
http://investorshub.advfn.com/STOCKGOODIES-PLAYS-OF-THE-WEEK-18582/
Photo Chick
Ospreyeye
Pistol Pete
Nilbud
imgoingfishing1
RECOMMENDED LINKS:
- FEATURE HISTORIANS CREATURES HIGHLIGHTS: http://investorshub.advfn.com/Weekend-Warrior$-27071/
- BUD-X-EXCHANGE HUGE MARIJUANA CANNABIS HEMP FINDS
- STOCKGOODIES PLAYS OF THE WEEK
- http://Pennystocksinsiders.com
- Billionaire Boys Club Member Forum (BBCMF
- INTELLECTUAL STOCK INVESTOR { I S I
- $$$Ospreyeye: Charts, Technical Analysis & Japanese
-Best of iHub
Moderator: JAYLIN Assistants: OTCRIDDLER, OTC_Skywalker, Sonic Boom, norcalpsl, Penny Soldier
LINKS
http://www.thehotpennystocks.com/Stock-Quotes/?stock=VTPI
http://www.quotemedia.com/
http://www.quotemedia.com/finance/quote/?qm_page=73166&qm_symbol=EFFI
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
1
|
Posts (Total)
|
54869
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |